Skip to main content

The BIO Investor Forum is BACK!

As one of the only independent partnering events dedicated to showcasing drug development programs that are ready for partnering or venture funding, the BIO Investor Forum is focused on accelerating the progress of new therapeutic technologies into commercialization and treating patients. 

The event features two days of candid panel discussions on policy, business, financing, and R&D along with company presentations, and BIO One-on-One Partnering™ meetings. At the BIO Investor Forum in 2019, there were more than 3,000 Partnering meetings scheduled.

WHO SHOULD ATTEND?      SEE THE PROGRAM

WHO'S PARTNERING

Watch the Event Preview and Partnering Tips Webinar

webinar screen

NEW for 2023! BIO Seed-Stage Spotlight on Tech Transfer

A new, half-day, pre-conference event on October 16 featuring presentations from seed-stage companies with academic IP ready for investment and industry partners. These companies have been incubated and advised by experienced tech transfer organizations.  

LEARN MORE

Who Should Attend?

Executives

Established private Biotech Companies and C-Suite

Biotech and Biopharma BD Executives

Innovators

"Pre-emerging" biotech and related companies, qualifying as seed and A-round companies that have raised since founding up to $15M

Investors

Private Equity

VCs and Angel Investors

Institutional Investors

Incubators/Innovation Centers

Academic Institutions

Past Sponsors Have Included:

Aon Risk Solutions  

Avantor     

Blaise Group International     

Bristol Myers Squibb Company

CHUBB

Eli Lilly and Company     

H.C. Wainwright & Company    

Locust Walk     

Lonza Group Ltd     

Merck     

The Money Channel NYC     

Morrison & Foerster, LLP    

NDA Group     

Novotech     

Nucleus Network Pty Ltd    

PharmaDirections, Inc.     

Proactive Investors  

ShareVault     

Sterling Bay, LLC    
 

SPONSOR THE 2023 EVENT

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS